A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ED / emitted dose

[Related PubMed/MEDLINE]
Total Number of Papers: 28
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ED  (>> Co-occurring Abbreviation)
Long Form:   emitted dose
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling. CFD, DAC, DPI, MMAD
2019 In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug. FPF, GSD, MDI, MMAD
2019 Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections. EE, FPF, PDI, USFD
2019 Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler. CFD, MMAD
2019 Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD. FPF, MMAD, NCMPs, NPs
2019 Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes. CFD, DAC, MMAD
2018 Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy. DPIs, EEG, LFNC
2018 Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance. DPI, FPF
2018 Development of an Inline Dry Powder Inhaler That Requires Low Air Volume. AS, DPIs, EEG, LV, MMAD, SS, ST
10  2018 Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation. DPIs, FPF, LAC_E, LAC_R, SS
11  2015 Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design. DPI, EEG
12  2015 Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers. FPF, GSD, MMAD, SX
13  2015 Potential of aerosolized rifampicin lipospheres for modulation of pulmonary pharmacokinetics and bio-distribution. FPF, GSD, MMAD
14  2014 Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations. CC, DPIs, FPFs, MMAD, NDSD
15  2014 Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications. CC, DPI, EEG
16  2014 Development of high efficiency ventilation bag actuated dry powder inhalers. HFNC
17  2014 Evaluation of sildenafil pressurized metered dose inhalers as a vasodilator in umbilical blood vessels of chicken egg embryos. CDs, FPF, MMAD, pMDI
18  2014 Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance. CAE, DPI, EE, FPF, MMAD, MMD, MNLC
19  2014 Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients. FP, FPM, NGI
20  2014 Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. CPPs, CQAs, FPD
21  2013 Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. CLM, co-SD, CRM, DPIs, DPPC, DSC, FPF, GVS, HSM, KFT, LSD, RF, SD, SEM, VCM, XRPD
22  2013 [Preparation, in vitro evaluation of excipient-free dry powder inhalation of extraction of Trollius chinensis]. DPI, FPF, TCB
23  2010 Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler. DPI, FPF, SS
24  2010 Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier. ACI, Bd, FPF, HA, LA
25  2009 Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders. FPF, PVD
26  2005 SCF-engineered powders for delivery of budesonide from passive DPI devices. DPI, FPF
27  2001 Delivery of HFA and CFC salbutamol from spacer devices used in infancy. pMDIs
28  2000 Emitted doses of salbutamol pressurized metered-dose inhaler from five different plastic spacer devices. ---